Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex

Neuropsychopharmacology

Volumn 22, Issue 6, 2000, Pages 642-649

  Gessa, Gian Luigi ^a,b,c   Devoto, Paola ^a   Diana, Marco ^b   Flore, Giovanna ^c   Melis, Miriam ^c   Pistis, Marco ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c And Neuroscience SCARL ^*  (Italy)

Author keywords

Antipsychotics; Dopamine; Electrophysiology; Microdialysis; Prefrontal cortex; Schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; HALOPERIDOL; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ELECTRIC ACTIVITY; MALE; MICRODIALYSIS; NERVE CONDUCTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ACTION POTENTIALS; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DOPAMINE; HALOPERIDOL; MALE; NEURONS; PIRENZEPINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 0034050617     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00087-7     Document Type: Article

References (39)

1. Brunello N, Masotto C, Steardo L, Markstein R, Racagni G (1995): New insight into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213
2. Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973): Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. Pharmacol Exp Ther 185:560-571
3. Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA, Calligaro DO (1999): Olanzapine: A basic science update. Br J Psychiatry 174(37):S36-S40
4. Chiodo LA, Bunney BS (1983): Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619
5. Creese I, Burt DR, Snyder SH (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483
6. Daniel DG, Weinberger DR, Jones DW (1991): The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11:1907-1917
7. Deutch AY (1992): The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm 36:61-89
8. Diana M, Garcia-Munoz M, Richards J, Freed CR (1989): Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats. Exp Brain Res 74:625-630
9. Fadda F, Cessa GL, Marcou M, Mosca E, Rossetti ZL (1984): Evidence for dopamine autoreceptors in mesocortical dopamine neurons. Brain Res 283:67-72
10. Gariano RF, Groves PM (1988): Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res 462:194-198
11. Gariano RF, Tepper JM, Sawyer SF, Young SJ, Groves PM (1989): Mesocortical dopamine neurons. I. Electrophysiological properties and evidence for soma-dendritic autoreceptors. Brain Res Bull 22:511-516
12. Grace AA, Bunney BS (1983): Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. I. Identification and characterization. Neuroscience 10:301-315
13. Grace AA, Bunney BS (1984): The control of firing pattern in nigral dopamine neurons: Burst firing. J Neurosci 4:2877-2890
14. Hand TH, Xiu-Ti H, Wang RY (1987): Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 415:257-269
15. Kuroki T, Meltzer HY, Ichikawa J (1999): Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288:774-781
16. Lee S-HL, Oh D-Y, Jung S-C, Kim Y-M, Cho H-K, Koh J-K, Lee Y-S (1997): Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: A possible mechanism for drug-induced tardive dyskinesia. Pharmacol Res 35:447-450
17. Li X-M, Perry KW, Wong DT, Bymaster FP (1998): Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153-161
18. Lidow MS, Williams GV, Goldman-Rakic PS (1998): The cerebral cortex: A case for a common site of action of antipsychotics. Trends Pharmacol Sei 19(4):136-140
19. Lipski J (1981): Antidromic activation of neurones as an analytic tool in the study of the central nervous system. J Neurosci Methods 4(l):l-32
20. Melis M, Diana M, Cessa GL (1999): Clozapine potently stimulates mesocortical dopamine neurons. Eur J Pharmacol 366:R11-R13
21. Meltzer HY, Stahl SM (1976): The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 2:19-76
22. Moghaddam B, Bunney BS (1990): Acute effect of typical and atypical antipsychotic drugs on the release of dopamine from the prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J Neurochem 54:1755-1760
23. Nomikos GG, lurlo M, Andersson JL, Kimura K, Svensson TH (1994): Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147-156
24. Oades RD, Halliday GM (1987): Ventral tegmental (A10) system: neurobiology. I. Anatomy and connectivity. Brain Res Rev 12:117-165
25. Paxinos G, Watson C (1986): The rat brain in stereotaxic coordinates. New York, Academic Press
26. Pehek EA, Yamamoto BK (1994): Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63:2118-2124
27. Pehek EA (1996): Local infusion of the serotonin antagonist ritanserin or ICS 205,930 increases in vivo dopamine release in the rat prefrontal cortex. Synapse 24(1):12-18
28. Pucak ML, Grace AA (1994): Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 271(3):1181-1192
29. Rollema H, Lu Y, Schmidt AW, Zorn SH (1997): Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Eur J Pharmacol 338(2):R3-R5
30. Sawaguchi T, Goldman-Rakic PS (1991): D, dopamine receptors in the prefrontal cortex. Involvement in working memory. Science 251:947-950
31. Scatton B, Dennis T, Curet O (1984): Increase in dopamine and DOPAC levels in noradrenergic terminals after electrical stimulation of the ascending noradrenergic pathways. Brain Res 298:193-196
32. Schmidt CJ, Fedayel GM (1995): The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 273(3):273-279
33. Seeman P, Lee T, Chau-Wong M, Wong K (1976): Antipsychotic drug doses and neuroleptic/ dopamine receptors. Nature 261:717-719
34. Snyder SH (1976): The dopamine hypothesis of schizophrenia: Focus on the dopamine receptor. Am J Psychiatry 1 33(2):197-202
35. Stockton ME, Rasmussen K (1996): Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology 14(2):97-104
36. Volonté M, Monferini E, Cerutti M, Fodritto F, Borsini (1997): BIMG 80, a novel potential antipsychotic drug: Evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J Neurochem 69:182-190
37. Weinberger DR (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
38. White FJ, Wang RY (1983): Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057
39. Wolf MR, Roth RH (1987): Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors. Neuropharmacology 26:1053-1059